cancer
Conditions
Interventions
intervention roup:Set up a medical follow-up team
intervention group:The follow-up system APP was established, which included the common adverse reactions checked by patients and the questionnaire for evaluation end points
intervention group:Assist the patient to register the APP
intervention group:Patients checked the possible side effects every week and uploaded the results of out-of-hospital examination as required
intervention Group:Patients with minor adverse reactions were followed up by telephone
intervention group:The App also included an algorithm for assessing the severity of symptoms or examination results according to NCI-CTCAE. Upon the occurrence of a grade 3 or 4 irAE, an urgency algor
control group:21 days of outpatient or inpatient visits and 3 months of telephone follow-up
control group:visit outpatient department when discomfort
Sponsors
Beijing Cancer Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Diagnosis of cancer by pathology or histology 2. If the immunotherapy criteria are met, immunotherapy will be applied 3. The patients can understand the purpose of the test, voluntarily participate in and sign the informed consent, and are willing to complete the follow-up according to the requirements of the protocol; 4. Clearly aware and able to answer questions correctly 5. Smart mobile devices with 3G/4G/5G functions that can use mobile phones and access the Internet
Exclusion criteria
Exclusion criteria: 1. ECOG score >= 2; 2. The researchers judged life expectancy to be less than six months; 3. According to the judgment of the researcher, patients with accompanying diseases (such as severe mental illness, severe major organ failure, serious heart disease, etc.) that seriously endanger the safety of patients or affect the completion of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment completion rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of immune-related grade 3-4 serious adverse reactions;Patient mortality due to severe adverse reactions;ER visits;quality of life; | — |
Countries
China
Contacts
Public ContactXiaotian Zhang
Beijing Cancer Hospital
Outcome results
None listed